- Home
- SRG vs PALI Comparison
SRG vs PALI Comparison
Compare SRG & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.83
HOLD
Current Price
$1.99
Company Overview
Basic Information| Metric | SRG | PALI |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.7M | 240.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SRG | PALI |
|---|---|---|
| Price | $2.83 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 191.3K | ★ 2.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $2.43 | $0.55 |
| 52 Week High | $4.56 | $2.64 |
Technical Indicators
Market Signals| Indicator | SRG | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 59.78 |
| Support Level | $2.83 | $1.58 |
| Resistance Level | $3.68 | $2.21 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 33.82 | 82.47 |
Price Performance
Historical Comparison SRG
PALI
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.